Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123419293 | 12341929 | 3 | F | 201603 | 20160712 | 20160506 | 20160714 | EXP | PHHY2016CO062707 | NOVARTIS | 73.27 | YR | M | Y | 50.00000 | KG | 20160714 | CN | COUNTRY NOT SPECIFIED | CO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123419293 | 12341929 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 2 DF, Q12H | 22068 | 2 | DF | CAPSULE | Q12H | ||||||
| 123419293 | 12341929 | 2 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0.5 MG, Q12H | U | 0 | .5 | MG | TABLET | Q12H | |||||
| 123419293 | 12341929 | 3 | C | ENALAPRIL | ENALAPRIL | 1 | Oral | 20 MG, Q12H | U | 0 | 20 | MG | TABLET | Q12H | |||||
| 123419293 | 12341929 | 4 | C | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 850 MG, Q12H | U | 0 | 850 | MG | CAPSULE | Q12H | |||||
| 123419293 | 12341929 | 5 | C | LOVASTATIN. | LOVASTATIN | 1 | Oral | 50 MG, QD (EVERY EVENING) | U | 0 | 50 | MG | TABLET | QD | |||||
| 123419293 | 12341929 | 6 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Oral | 100 MG, QD (EVERY EVENING) | U | 0 | 100 | MG | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123419293 | 12341929 | 1 | Chronic myeloid leukaemia |
| 123419293 | 12341929 | 2 | Blood pressure abnormal |
| 123419293 | 12341929 | 3 | Blood pressure abnormal |
| 123419293 | 12341929 | 4 | Diabetes mellitus |
| 123419293 | 12341929 | 5 | Product used for unknown indication |
| 123419293 | 12341929 | 6 | Blood pressure abnormal |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123419293 | 12341929 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123419293 | 12341929 | Anaemia | |
| 123419293 | 12341929 | Malaise | |
| 123419293 | 12341929 | Movement disorder | |
| 123419293 | 12341929 | Speech disorder | |
| 123419293 | 12341929 | Terminal state |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123419293 | 12341929 | 1 | 20140729 | 0 |